miRagen Therapeutics Expands Executive Leadership Team Adding Drug Development Veteran

miRagen Therapeutics, Inc., a biopharmaceutical company discovering and developing innovative microRNA (miRNA)-targeting therapeutics, today announced the appointment of David Rodman, M.D. to the position of Executive Vice President of Research and Development. Dr. Rodman is an accomplished industry veteran who brings significant translational medicine and clinical development experience to the company’s executive leadership team.

Help employers find you! Check out all the jobs and post your resume.